Mutations in myeloid neoplasms.
The introduction of molecular techniques in the study of myeloid neoplasms has resulted in the identification of numerous genetic abnormalities with diagnostic and prognostic significance. The impact of these recent discoveries cannot be understated, as the definitions of several myeloid neoplasms have been changed to include new, molecular criteria. Also, the presence of molecular abnormalities with prognostic significance can impact the therapeutic decisions in many cases. This review is directed to an audience of clinical and laboratory professionals involved in the diagnosis and management of myeloid neoplasms, and it aims to succinctly present the most important genes that have been shown to be important in these disorders. In addition to the information about mutations, their significance, and the methods used in their diagnosis, the normal patterns of expression of these genes, their normal functions, and their structures are also discussed.